Skip to main content

Animations

MJFF Publications

7061 - 7070 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2025
  • 2006
  • 2021
  • 2020
  • 2011
  • 2023
  • 2014
  • 2024
  • 2020
  • Summary Details
    OPEN
    Title: High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2406009121
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Liganded magnetic nanoparticles for magnetic resonance imaging of α-synuclein
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00918-z
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Crossroads in GDNF therapy for Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.20861
    Citation Count: 175
  • Summary Details
    OPEN
    Title: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28715
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Increased glutamate transmission onto dorsal striatum spiny projection neurons in Pink1 knockout rats
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2020.105246
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Rotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 Cases
    Journal Name: Sleep Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2011/468952
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Distribution of cholinergic nerve terminals in the aged human brain measured with [18F]FEOBV PET and its correlation with histological data
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2023.119908
    Citation Count: 19
  • Summary Details
    RESTRICTED
    Title: High Stability and Cooperative Unfolding of α-Synuclein Oligomers
    Journal Name: Biochemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/bi5007833
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders
    Journal Name: Genetics in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.gim.2024.101251
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synuclein
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.brainres.2020.147131
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.